1,4-Diaryl-1,2,3-triazole neolignan-celecoxib hybrids inhibit experimental arthritis induced by zymosan.
Felipe JL, Bonfá IS, Lossavaro PKMB, Lencina JS, B Carvalho D, Candeloro L, Ferreira GIS, das Neves AR, Souza MIL, Silva-Filho SE, Baroni ACM, Toffoli-Kadri MC.
Felipe JL, et al.
Inflammopharmacology. 2023 Dec;31(6):3227-3241. doi: 10.1007/s10787-023-01345-3. Epub 2023 Oct 8.
Inflammopharmacology. 2023.
PMID: 37806984